Trials / Unknown
UnknownNCT03089450
To Evaluate Safety and Efficacy of CGBIO Stent Compared to Biomatrix Flex Stent
A Multicenter, Subject-blinded, Randomized Study to Evaluate Safety and Efficacy of CGBIO Stent Compared to Biomatrix Flex Stent in Patients Undergoing Drug-eluting Stent Procedure After Coronary Angiography
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 112 (estimated)
- Sponsor
- CGBio Inc. · Industry
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
to evaluate safety and efficacy of CGBIO stent(DES) compared to Biomatrix flex stent(DES)
Detailed description
A Multicenter, subject-blinded, randomized study to evaluate safety and efficacy of CGBIO stent compared to Biomatrix Flex stent in patients undergoing drug-eluting stent procedure after coronary angiography
Conditions
- Ischemic Heart Disease
- Stable Coronary Artery Disease
- Stable Angina
- Unstable Angina
- NSTEMI - Non-ST Segment Elevation MI
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CGBio stent | Percutaneous Coronary Intervention |
| DEVICE | Biomatrix flex | Percutaneous Coronary Intervention |
Timeline
- Start date
- 2017-03-22
- Primary completion
- 2017-09-01
- Completion
- 2018-06-01
- First posted
- 2017-03-24
- Last updated
- 2017-03-28
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03089450. Inclusion in this directory is not an endorsement.